🔎 Trials Near Me

Početna › Difuzni veliki B-stanični limfom › Pennsylvania › Philadelphia

Kliničke studije za Difuzni veliki B-stanični limfom u gradu Philadelphia, PA

15 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Philadelphia i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

U tijeku regrutacijaFaza 2
  • Fox Chase Cancer Center, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06500273

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

U tijeku regrutacijaOpažajna studija
  • Children's Hospital of Philadelphia, Philadelphia
Od 0 do 38 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06131801

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • Thomas Jefferson University Hospital, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06649812

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

U tijeku regrutacijaFaza 2/3
  • Alliance Cancer Specialists (ACS) ( Site 8001), Horsham · 16 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05139017

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

U tijeku regrutacijaFaza 2
  • Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131), Philadelphia
  • Temple University Hospital ( Site 0133), Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06890884

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

U tijeku regrutacijaFaza 1
  • University of Pennsylvania Abramson Cancer Center, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

U tijeku regrutacijaFaza 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

U tijeku regrutacijaFaza 1/2
  • Thomas Jefferson University, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

U tijeku regrutacijaFaza 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT04104776

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

U tijeku regrutacijaFaza 1
  • University of Pennsylvania / Abramson Cancer Center, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05077527

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

U tijeku regrutacijaFaza 1
  • University of Pennsylvania, Abramson Cancer Center, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

U tijeku regrutacijaFaza 1
  • Abramson Cancer Center, University of Pennsylvania, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT07478848

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

U tijeku regrutacijaFaza 2
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT06458439

SynKIR-310 for Relapsed/Refractory B-NHL

U tijeku regrutacijaFaza 1
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT06544265

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
Od 18 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT05633615

Studije za Difuzni veliki B-stanični limfom u drugim gradovima

Ostale studije u gradu Philadelphia

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.